Literature DB >> 7372340

The chromosome changes in non-Burkitt lymphomas.

B R Reeves, V L Pickup.   

Abstract

Cytogenetic analysis of 26 non-Burkitt lymphomas having abnormal clones, revealed non-random involvement of certain chromosomes in numerical and structural changes. In some cases, chromosome structural abnormalities could be correlated with histopathology of the tumours. A combined analysis of cases in the present series, and from the literature, indicates that the most common aberrations in the lymphoproliferative disorders involve structural changes of chromosome 14.

Entities:  

Mesh:

Year:  1980        PMID: 7372340     DOI: 10.1007/bf00287055

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  26 in total

1.  Clonal growth of Hodgkin cells.

Authors:  W R Boecker; D K Hossfeld; W M Gallmeier; C G Schmidt
Journal:  Nature       Date:  1975-11-20       Impact factor: 49.962

2.  Characteristic chromosomal abnormalities in biopsies and lymphoid-cell lines from patients with Burkitt and non-Burkitt lymphomas.

Authors:  L Zech; U Haglund; K Nilsson; G Klein
Journal:  Int J Cancer       Date:  1976-01-15       Impact factor: 7.396

3.  Letter: Marker-chromosome 14 in multiple myeloma and plasma-cell leukaemia.

Authors:  D H Wurster-Hill; O R McIntyre; G G Cornwell; L H Maurer
Journal:  Lancet       Date:  1973-11-03       Impact factor: 79.321

4.  New approaches to the classification of the lymphomata.

Authors:  R J Lukes; R D Collins
Journal:  Br J Cancer Suppl       Date:  1975-03

5.  Histiocytic lymphomas with the marker chromosome 14q+.

Authors:  J Mark
Journal:  Hereditas       Date:  1975       Impact factor: 3.271

6.  14q+ marker chromosomes in multiple myeloma and plasma-cell leukaemia.

Authors:  W Liang; J D Rowley
Journal:  Lancet       Date:  1978-01-14       Impact factor: 79.321

7.  Clustering of aberrations to specific chromosomes in human neoplasms. III. Incidence and geographic distribution of chromosome aberrations in 856 cases.

Authors:  F Mitelman; G Levan
Journal:  Hereditas       Date:  1978       Impact factor: 3.271

8.  G-banding analysis of complex aneuploidy in multiple myeloma bone marrow cells.

Authors:  P Philip; A Drivsholm
Journal:  Blood       Date:  1976-01       Impact factor: 22.113

9.  Karyotype peculiarities of malignant lymphomas.

Authors:  E W Fleischman; E L Prigogina
Journal:  Hum Genet       Date:  1977-03-14       Impact factor: 4.132

10.  A 14q+ marker and a late replicating chromosome No. 22 in a brain tumor: brief communication.

Authors:  K Yamada; M Yoshioka; H Oami
Journal:  J Natl Cancer Inst       Date:  1977-10       Impact factor: 13.506

View more
  6 in total

1.  Chromosome abnormalities in peripheral blood lymphocytes from untreated Hodgkin's patients. A possible evidence for chromosome instability.

Authors:  L Barrios; M R Caballín; R Mirò; C Fuster; G Berrozpe; A Subías; X Batlle; J Egozcue
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

2.  Karyotype analysis of B-lymphocytes transformed by Epstein-Barr virus in 21 patients with B cell chronic lymphocytic leukemia.

Authors:  M Vahdati; H Graafland; J M Emberger
Journal:  Hum Genet       Date:  1983       Impact factor: 4.132

3.  Cytogenetic findings in T-zone lymphoma.

Authors:  E Gödde-Salz; E W Schwarze; H Stein; K Lennert; W Grote
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

4.  t(6;14)(q15;q32) in a patient with CD5+CD10+ diffuse large B-cell lymphoma.

Authors:  Miyuki Hayama; Nozomi Niitsu; Masaaki Higashihara; Hirokazu Nakamine; Ikuo Miura
Journal:  Int J Hematol       Date:  2007-08       Impact factor: 2.490

5.  The gene for the type II (p75) tumor necrosis factor receptor (TNF-RII) is localized on band 1p36.2-p36.3.

Authors:  O Kemper; J Derré; D Cherif; H Engelmann; D Wallach; R Berger
Journal:  Hum Genet       Date:  1991-09       Impact factor: 4.132

Review 6.  Tumor necrosis factor receptor 2: its contribution to acute cellular rejection and clear cell renal carcinoma.

Authors:  Jun Wang; Rafia S Al-Lamki
Journal:  Biomed Res Int       Date:  2013-11-17       Impact factor: 3.411

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.